Your session is about to expire
← Back to Search
Oxygen Saturation Target for Newborn Pulmonary Hypertension (POST-IT Trial)
POST-IT Trial Summary
This trial is testing what oxygen saturation levels are best for newborns with pulmonary hypertension. Newborns will be randomly assigned to one of two oxygen saturation goals, and their progress will be monitored.
POST-IT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPOST-IT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.POST-IT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My condition is often fatal in infancy, like trisomy 18 or 13.My baby is 28 days old or younger.My baby is more than 34 weeks and 6 days old, counting from conception.I was born before reaching 32 weeks of pregnancy.I have severe respiratory failure and have been on a ventilator for over an hour despite treatments.My weight is less than 2000 grams at enrollment.I have a heart condition, but it's not ASD/PFO, PDA, or VSD.My infant has CDH, Down syndrome, HIE, PDA, PFO/ASD, or VSD less than 2 mm.An echocardiogram shows signs of pulmonary hypertension.I am on a breathing machine or need high oxygen support.
- Group 1: Standard arm
- Group 2: Intervention arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this medical trial accommodate participants under the age of thirty?
"This trial is seeking infants aged between 0 and 28 days. Furthermore, there are 829 studies targeting individuals over the age of 65 and 86 trials focussing on younger participants."
Are new participants still being accepted into this experiment?
"This clinical trial, first posted on August 1st 2021 and last updated January 25th 2022, is not currently seeking patients. Nevertheless, there are 936 other medical studies that are actively recruiting participants at this point in time."
Who is eligible to take part in this research investigation?
"Eligibility to participate requires a diagnosis of pulmonary hypertension, and the age range for participants is 0 days up to 28 days. At present, our team needs 30 patients to join this clinical trial."
Share this study with friends
Copy Link
Messenger